- Trials with a EudraCT protocol (36)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
36 result(s) found for: Neuronal Activity.
Displaying page 1 of 2.
EudraCT Number: 2015-000891-85 | Sponsor Protocol Number: 190-203 | Start Date*: 2017-09-05 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc | |||||||||||||
Full Title: A Phase 2, Open-Label, Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Intracerebroventricular BMN 190 in Pediatric Patients < 18 years of age with CLN2 Disease | |||||||||||||
Medical condition: Neuronal Ceroid Lipofuscinosis type 2 (CLN2) disease | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005430-11 | Sponsor Protocol Number: 190-201 | Start Date*: 2013-08-15 | |||||||||||
Sponsor Name:BioMarin Pharmaceutical Inc. | |||||||||||||
Full Title: A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients with Late-Infantile Neuronal Ceroid Lipo... | |||||||||||||
Medical condition: Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2). | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002161-56 | Sponsor Protocol Number: NeM-CSM-FT-01 | Start Date*: 2017-04-13 |
Sponsor Name:Mateusz Gola | ||
Full Title: Towards the understanding of neuronal mechanisms of compulsive sexual behaviors - pharmacotherapy | ||
Medical condition: compulsive sexual behavior (hypersexual disorder) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: PL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000980-26 | Sponsor Protocol Number: CALPET01 | Start Date*: 2007-05-11 |
Sponsor Name:Fundación para la Investigación biomedica del Hospital Gregorio Marañon | ||
Full Title: "Estudio comparativo, randomizado y de grupos paralelos con PET en pacientes esquizofrénicos de nuevo diagnóstico en tratamiento con Aripiprazol y Risperidona" | ||
Medical condition: Schizophrenia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002636-82 | Sponsor Protocol Number: OTL-200-07 | Start Date*: 2019-12-02 | |||||||||||
Sponsor Name:Orchard Therapeutics (Europe) Limited | |||||||||||||
Full Title: An open label, non-randomised trial to evaluate the safety and efficacy of a single infusion of OTL-200 in patients with Late Juvenile (LJ) Metachromatic Leukodystrophy (MLD) | |||||||||||||
Medical condition: Metachromatic Leukodystrophy | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016446-50 | Sponsor Protocol Number: - | Start Date*: 2010-04-19 | |||||||||||
Sponsor Name:Maastricht University - CAPHRI School for Public Health and Primary Care | |||||||||||||
Full Title: Helping more smokers to quit by combining varenicline with counselling for smoking cessation. The COVACO randomized controlled trial. | |||||||||||||
Medical condition: Smoking: Subjects must be daily smokers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002680-34 | Sponsor Protocol Number: DEXPAR | Start Date*: 2016-10-20 | |||||||||||
Sponsor Name:Clínica Universidad de Navarra/Universidad de Navarra | |||||||||||||
Full Title: Effects of different concentrations of dexmedetomidine on basal ganglia neuronal activity (local field potentials) in Parkinson's disease. | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018181-36 | Sponsor Protocol Number: 09117 | Start Date*: 2010-02-23 |
Sponsor Name:University of Nottingham | ||
Full Title: Nitrous Oxide and Functional Magnetic Resonance Imaging to investigate cerebral regional blood flow, cerebral metabolism and neuronal activity. | ||
Medical condition: This is part of a series of studies investigating the potential therapeutic use of low dose nitrous oxide in the treatment of cerebral vasospasm, a condition which occurs following brain injury and... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-004857-27 | Sponsor Protocol Number: F20REWARDLU | Start Date*: 2008-01-02 |
Sponsor Name:Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University Munich | ||
Full Title: Ventral striatal function in patients with schizophrenia before and under medication with atypical antipsychotics: a comparison of sertindole and risperidone | ||
Medical condition: schizophrenic patients (F20.0, F20.1, F20.2, F20.3, F20.5, F20.6, F20.8, F20.9) and healthy controls | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000841-28 | Sponsor Protocol Number: DC2017DECREASE01 | Start Date*: 2017-08-14 |
Sponsor Name:VU University Medical Center | ||
Full Title: Combined effects of SGLT2 inhibition and GLP-1 receptor agonism on food intake, body weight and central satiety and reward circuits in obese T2DM patients | ||
Medical condition: Type 2 diabetes mellitus Obesity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005696-17 | Sponsor Protocol Number: 1645-CI-058 | Start Date*: 2013-06-18 |
Sponsor Name:Instituto de Investigacion Sanitaria La Fe | ||
Full Title: Multicenter, randomized, blinded clinical study comparing early use of total body moderate hypothermia plus topiramate or placebo in asphyxiated newborn infants evolving to moderate-to-severe hypox... | ||
Medical condition: Asphyxiated newborn infants evolving to moderate-to-severe hypoxic ischemic encephalopathy | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005947-22 | Sponsor Protocol Number: SIPO20 | Start Date*: 2021-11-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: Effect of siponimod on relevant imaging and immunological hallmarks of progressive multiple sclerosis | |||||||||||||
Medical condition: Active progressive MS course after an initial relapse clinical course | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004833-25 | Sponsor Protocol Number: UNLOCK | Start Date*: 2017-03-29 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) | ||
Full Title: Synchronous effect of anesthetics on fMRI, EEG and clinical responses. Development of a more precise system for monitoring anesthetic effect. | ||
Medical condition: General anaesthesia in healthy subjects | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001802-32 | Sponsor Protocol Number: C1501 | Start Date*: 2015-08-14 | |||||||||||
Sponsor Name:Biologische Heilmittel Heel GmbH | |||||||||||||
Full Title: Neuronal correlates of Neurexan® action in mildly to moderately stressed probands - a randomized, placebo-controlled, double-blind, cross-over trial of mode of action and response prediction by fun... | |||||||||||||
Medical condition: mildly to moderately stressed probands | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2023-000018-16 | Sponsor Protocol Number: OZA22/IM047-048 | Start Date*: 2023-04-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: Effect of ozanimod on meningeal inflammation and glial activation in Multiple Sclerosis: one year phase 4 experimental study | |||||||||||||
Medical condition: Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003313-42 | Sponsor Protocol Number: AGO-TEA | Start Date*: 2012-03-29 |
Sponsor Name:Hospital General Universitario de Alicante | ||
Full Title: Efficacy of agomelatine on sleep disturbance in Autism Spectrum Disorder (ASD) | ||
Medical condition: The treatment of sleep disorders in patients with autism spectrum disorders (ASD) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005394-31 | Sponsor Protocol Number: 12/0219 | Start Date*: 2014-04-01 |
Sponsor Name:UCL | ||
Full Title: MS-SMART: A Multi-Arm Phase IIb Randomised, Double Blind Placebo-Controlled Clinical Trial Comparing The Efficacy of Three Neuroprotective Drugs in Secondary Progressive Multiple Sclerosis | ||
Medical condition: Mutliple Sclerosis (Secondary Progressive) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000274-35 | Sponsor Protocol Number: DOLAM | Start Date*: 2015-04-23 | |||||||||||
Sponsor Name:FUNDACIÓ CLÍNIC PER A LA RECERCA BIOMÈDICA | |||||||||||||
Full Title: An open-label, randomized, controlled clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged viro... | |||||||||||||
Medical condition: Infection with human immunodeficiency virus (HIV). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005899-36 | Sponsor Protocol Number: CLOU064C12301 | Start Date*: 2022-02-21 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by... | |||||||||||||
Medical condition: Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Ongoing) IT (Ongoing) ES (Ongoing) NL (Ongoing) BE (Ongoing) BG (Ongoing) LV (Ongoing) HR (Ongoing) LT (Ongoing) AT (Ongoing) DK (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005929-89 | Sponsor Protocol Number: CLOU064C12302 | Start Date*: 2022-02-01 |
Sponsor Name:Novartis Pharma AG | ||
Full Title: A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by... | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) IT (Ongoing) GR (Ongoing) ES (Ongoing) PT (Ongoing) SI (Ongoing) SK (Ongoing) BG (Ongoing) PL (Ongoing) HR (Ongoing) EE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.